- Home
- MIRM vs UPST Comparison
MIRM vs UPST Comparison
Compare MIRM & UPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MIRM | UPST |
|---|---|---|
| Founded | 2018 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 4.7B |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MIRM | UPST |
|---|---|---|
| Price | $101.26 | $33.73 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 16 |
| Target Price | ★ $119.85 | $45.84 |
| AVG Volume (30 Days) | 1.0M | ★ 4.5M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 74.59 | ★ 131.25 |
| EPS | N/A | ★ N/A |
| Revenue | $19,138,000.00 | ★ $1,043,857,000.00 |
| Revenue This Year | $26.22 | $34.45 |
| Revenue Next Year | $22.04 | $32.64 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 63.99 |
| 52 Week Low | $43.50 | $23.97 |
| 52 Week High | $114.99 | $85.31 |
Technical Indicators
Market Signals| Indicator | MIRM | UPST |
|---|---|---|
| Relative Strength Index (RSI) | 51.95 | 64.31 |
| Support Level | $95.68 | $25.18 |
| Resistance Level | $107.51 | $35.80 |
| Average True Range (ATR) | 5.22 | 1.82 |
| MACD | -0.65 | 0.49 |
| Stochastic Oscillator | 33.42 | 90.32 |
Price Performance
Historical ComparisonAbout MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
About UPST Upstart Holdings Inc.
Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. Upstart's platform includes personal loans, automotive retail and refinance loans, home equity lines of credit, and small-dollar loans.